Samalizumab
Product Specifications
CAS Number
1073059-33-2
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.9564
Bioactivity
Samalizumab (ALXN 6000) is a humanized anti-CD200 monoclonal antibody that specifically targets the CD200 immunoregulatory cell surface protein, a member of the immunoglobulin superfamily which functions to dampen excessive immune responses and maintain self-tolerance, thereby establishing Samalizumab as an effective immune checkpoint inhibitor currently under investigation for the treatment of myeloma and B-cell chronic lymphocytic leukemia (CLL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-F862385-10MG 10 mg
(E)-2-Furaldehyde, (2,4-Dinitrophenyl)hydrazone
Sign In for Pricing
View Details 
44462124 3x 1.0µg DNA
Smok2b CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Sign In for Pricing
View Details 